CWA Asset Management Group’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.23M Buy
61,273
+14,672
+31% +$463K 0.07% 259
2026
Q1
$1.31M Buy
46,601
+6,484
+16% +$213K 0.04% 343
2025
Q4
$1.5M Buy
40,117
+1,384
+4% +$45.5K 0.05% 287
2025
Q3
$1.07M Buy
38,733
+9,514
+33% +$328K 0.04% 340
2025
Q2
$923K Buy
29,219
+5,665
+24% +$182K 0.04% 340
2025
Q1
$782K Buy
23,554
+5,275
+29% +$189K 0.04% 339
2024
Q4
$629K Buy
18,279
+3,883
+27% +$133K 0.03% 345
2024
Q3
$576K Buy
+14,396
New +$506K 0.03% 336

Other funds holding HRMY